AVLNAvalyn Pharma Inc.
$25.70
$25.70
$25.3752 weeks$39.39
The financials
Avalyn Pharma Inc. by the numbers
The next results filing is expected around Nov 11, 2026, a quarter after the last one.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$31M | −$19M | n/a |
| Net income | −$29M | −$18M | n/a |
| Diluted EPS | −$0.98 | −$63.24 | n/a |
On our screens:Stocks with no debt
Biotechnology
The closest names by size in the same industry